Higher 3-year recurrence-free survival rate in patients with complete pathological remission following neoadjuvant chemotherapy plus immunotherapy for esophageal cancer: a two-center, propensity score matching study - Zhang, Hai; He, Haiquan; Feng, Qingyi; Wu, Bomeng; Chen, Ying; Zhang, Zhenyang; Zhou, Linrong; Li, Cui; Lin, Wanli; Lin, Jiangbo (Frontiers in Oncology, 2025)